Other News To Note
Friday, March 1, 2013
Novan Therapeutics Inc., of Durham, N.C., said in vitro and animal data indicated the firm's SB204, its drug candidate for acne, could lead to a topical treatment to reduce oil production in the skin.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.